Emerging within the UK, retatrutide, a innovative molecule, is sparking considerable excitement within the healthcare community regarding its ability for body management . This dual GIP and GLP-1 receptor agonist appears to provide a significant advantage over current therapies, showing promising results in early clinical assessments. Researchers b